Re: Side Effects of Bacillus Calmette-Guerin (BCG) in the Treatment of Intermediate- And High-Risk Ta, T1 Papillary Carcinoma ...

Journal of Urological Surgery
doi 10.4274/jus.2015.01.004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Galenos Yayinevi

Related search

Systemic Bacillus Calmette-Guerin (BCG) Activates Natural Suppressor Cells.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1978English

Bacillus Calmette–Guerin Immunotherapy for Urothelial Carcinoma of the Bladder

Immunotherapy
OncologyAllergyImmunology
2009English

Case: Bacillus Calmette-Guerin (BCG)-induced Reiter Syndrome With an Attempt at Repeat BCG Induction

Canadian Urological Association Journal
Urology
2017English

Role of IL-10 in Urinary Bladder Carcinoma and Bacillus Calmette-Guerin Immunotherapy

American Journal of Immunology
AllergyImmunology
2012English

Impact of in Vitro Evolution on Antigenic Diversity of Mycobacterium Bovis Bacillus Calmette-Guerin (BCG)

Vaccine
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
2014English

Tuberculous Psoas Abscess and Worsening Vascular Aneurysm; All From Bacillus Calmette-Guerin (BCG) Therapy?

American Journal of Case Reports
Medicine
2017English

Bovis Bacillus Calmette–Guerin (BCG) Infection Induces Exosomal miRNA Release by Human Macrophages

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2017English

Efficacy and Effectiveness of Vaccination With Bacillus Calmette-Guerin

Juntendo Medical Journal
2001English

Disseminated Granulomatous Disease From Intravesical Instillation of Bacillus Calmette-Guerin

Case Reports in Oncological Medicine
Oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy